Ignite Creation Date:
2025-12-24 @ 10:52 PM
Ignite Modification Date:
2026-01-02 @ 10:08 AM
Study NCT ID:
NCT02711969
Status:
COMPLETED
Last Update Posted:
2022-07-22
First Post:
2016-02-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Apatinib Mesylate (YN968D1) 1,000mg in Gastric Cancer Patient Failed to Standard Treatment
Sponsor:
Bukwang Pharmaceutical
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-03
Start Date Type:
None
Primary Completion Date:
2016-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-03
Completion Date Type:
ACTUAL
First Submit Date:
2016-02-26
First Submit QC Date:
None
Study First Post Date:
2016-03-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-07-20
Last Update Post Date:
2022-07-22
Last Update Post Date Type:
ACTUAL